Vironix remote physiological monitoring & disease-specific AI intelligence for respiratory and cardiovascular chronic illnesses

RPM Panel CCM

Full Physiological Monitoring

At Vironix, we create remote patient care products that save lives and raise quality-of-life for those afflicted with Heart Failure, COPD, Asthma, and Acute Respiratory Illness.

RPM Panel RPM
Remote Physiological Monitoring
RPM Panel CCM
Chronic Care Management
RPM Panel AI
AI & Automation

Our Motivation

Either you or someone you know has been impacted by heart or lung disease.

Heart

17.9 MILLION PEOPLE

die each year from cardiovascular disease.

That’s one death every 56 seconds.

People diagnosed with or at risk of heart failure, COPD, asthma, & acute respiratory illness face constant risk of death, hospitalization, massive healthcare expenditures, and persistent anxiety. If detected and managed early, singular health deterioration episodes, which include exacerbations & infections, can be readily addressed at home with diet, medications, and rest.

Lungs

$400 BILLION

is the cost of preventable heart and lung disease to employers and health insurance providers

Vironix managed API

Vironix's Managed API

Vironix’s API offers disease-specific intelligence at home. Enhance your products with clinically validated machine-learning algorithms for personalized, remote diagnostics and decision support.

Intelligence
Offer Intelligence
Dependencies included
Dependencies Included
Customizable & Flexible
Customizable & Flexible

Peer-Reviewed, World Class R&D

Clinically validated algorithms built by scientists and clinicians.

Heart Failure
Heart failure algorithms deliver highly accurate assessments (as compared to cardiologists and triage specialists) of when existing diuretic/BP therapy regimens are poorly optimized and patients should seek physician or hospital care.
Heart Failure
COPD
Chronic Lung Disease Models Outperform Pulmonary Critical Care Specialists in Identifying Clinically Significant Health Deterioration At-Home
COPD
Asthma
Pre/Post Observational trials show that minutes of weekly decision support app engagement yields clinically significant reduction in anxiety.
Asthma
Covid-19
Covid-19 algorithms exhibit strong accuracy, sensitivity, and specificity at diagnosing severe Covid-19 presentations in diverse global populations.
Covid-19
Influenza
Feature importance studies on influenza show minor variation in most important clinical characteristics associated with severe influenza when comparing two methods of patient training data generation.
Influenza

Recent News

Welcoming Ahmed Ammar Naseer to Vironix Health

Welcoming Ahmed Ammar Naseer to Vironix Health

2022-06-07

University of Oxford Masters Student, Ahmed Ammar Naseer, has joined Vironix’s modelling team to work on synthetic patient data generation and machine learning algorithms for predicting heart failure exacerbations. The results and methodologies developed in his internship project may help patients to improve their quality of life and reduce preventable emergency care episodes.

Welcoming Fareeha Shah To The Team

Welcoming Fareeha Shah To The Team

2022-05-27

Fareeha is a UX/UI/Design expert who has just come aboard. She will be working on improving the company’s externally facing materials (product UI/UX, website, social media, etc).

About Vironix

Vironix was formed by passionate scientists, physicians, technologists, and entrepreneurs who have amassed decades of research, development, and commercialization expertise in the development, testing, and commercialization of medical technology.

Team Photo

Vironix specializes in early detection and remote care of infectious and chronic illnesses. Visit our product pages to learn more about our RPM and API offerings, and take a look at our science page to see the depth of scientific rigor and human testing that has gone into Vironix’s innovations.